PUBLICATIONS · 16495393
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2006 Feb 23
- First author
- Joensuu H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2006 Feb 23;354(8):789-90. doi: 10.1056/NEJMp058315.
- note
- Source null
- related pmid
- 16495390
- relationship
- Comment in
- citation
- N Engl J Med. 2006 May 18;354(20):2186; author reply 2186. doi: 10.1056/NEJMc060852.
- note
- Source null
- related pmid
- 16707759
- relationship
- Comment in
Authors and identifiers
- name
- Joensuu H
- type
- Author
- name
- Kellokumpu-Lehtinen PL
- type
- Author
- name
- Bono P
- type
- Author
- name
- Alanko T
- type
- Author
- name
- Kataja V
- type
- Author
- name
- Asola R
- type
- Author
- name
- Utriainen T
- type
- Author
- name
- Kokko R
- type
- Author
- name
- Hemminki A
- type
- Author
- name
- Tarkkanen M
- type
- Author
- name
- Turpeenniemi-Hujanen T
- type
- Author
- name
- Jyrkkiö S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Joensuu H
- type
- Author
- name
- Kellokumpu-Lehtinen PL
- type
- Author
- name
- Bono P
- type
- Author
- name
- Alanko T
- type
- Author
- name
- Kataja V
- type
- Author
- name
- Asola R
- type
- Author
- name
- Utriainen T
- type
- Author
- name
- Kokko R
- type
- Author
- name
- Hemminki A
- type
- Author
- name
- Tarkkanen M
- type
- Author
- name
- Turpeenniemi-Hujanen T
- type
- Author
- name
- Jyrkkiö S
- type
- Author
- bibliography ids
- nci-bib-6b61f679483ae92952382433
- book metadata
- content sha256
- 5eea07378c1e849985fb99bf4d860aa7171be0b13ebbada55c0d57d5521ff9b8
- document type
- citation
- dois
- 10.1056/NEJMoa053028
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16495393
- immutable id
- pubmed:16495393@5eea07378c1e849985fb99bf4d860aa7171be0b13ebbada55c0d57d5521ff9b8
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 8
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 809-20
- volume
- 354
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2006 Feb 23;354(8):789-90. doi: 10.1056/NEJMp058315.
- note
- Source null
- related pmid
- 16495390
- relationship
- Comment in
- citation
- N Engl J Med. 2006 May 18;354(20):2186; author reply 2186. doi: 10.1056/NEJMc060852.
- note
- Source null
- related pmid
- 16707759
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 16495393
- provenance
- batch id
- a181c30258a88d182e78
- provider
- NCBI PubMed ESummary
- record sha256
- c52f5f85713721baf82f83dfbb1a215946a952c99ded6847d8abfff87decd34b
- response sha256
- 558e0dce453ae424567844b062522ebd1d27363c3312c81dbf6f32a8ff08da24
- retrieved at
- 2026-09-09T23:46:03.896343+00:00
- publication date
- display
- 2006 Feb 23
- precision
- day
- year
- 2006
- publication types
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
Preserved source evidence · Not medical advice
Triangle